HLA high-resolution typing by next-generation sequencing in Pandemrix-induced narcolepsy | Zendy

A. R. Lind | Zendy; Omar Akel | Zendy; Madeleine Wallenius | Zendy; Anita Ramelius | Zendy; Marlena Maziarz | Zendy; Lue Ping Zhao | Zendy; Daniel E. Geraghty | Zendy; Lars Palm | Zendy; Åke Lernmark | Zendy; Helena Elding Larsson | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

HLA high-resolution typing by next-generation sequencing in Pandemrix-induced narcolepsy

Author(s) -

A. R. Lind,

Omar Akel,

Madeleine Wallenius,

Anita Ramelius,

Marlena Maziarz,

Lue Ping Zhao,

Daniel E. Geraghty,

Lars Palm,

Åke Lernmark,

Helena Elding Larsson

Publication year - 2019

Publication title -

plos one

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.99

H-Index - 332

ISSN - 1932-6203

DOI - 10.1371/journal.pone.0222882

Subject(s) - haplotype , human leukocyte antigen , allele , typing , biology , genotype , genetics , population , narcolepsy , immunology , medicine , antigen , gene , environmental health , neurology , neuroscience

The incidence of narcolepsy type 1 (NT1) increased in Sweden following the 2009–2010 mass-vaccination with the influenza Pandemrix-vaccine. NT1 has been associated with Human leukocyte antigen ( HLA ) DQB1*06 : 02 but full high-resolution HLA-typing of all loci in vaccine-induced NT1 remains to be done. Therefore, here we performed HLA typing by sequencing HLA - DRB3 , DRB4 , DRB5 , DRB1 , DQA1 , DQB1 , DPA1 and DPB1 in 31 vaccine-associated NT1 patients and 66 of their first-degree relatives (FDR), and compared these data to 636 Swedish general population controls (GP). Previously reported disease-related alleles in the HLA - DRB5*01 : 01 : 01-DRB1*15 : 01 : 01-DQA1*01 : 02 : 01-DQB1*06 : 02 : 01 extended haplotype were increased in NT1 patients (34/62 haplotypes, 54.8%) compared to GP (194/1272 haplotypes, 15.3%, p = 6.17E -16 ). Indeed, this extended haplotype was found in 30/31 patients (96.8%) and 178/636 GP (28.0%). In total, 15 alleles, four extended haplotypes, and six genotypes were found to be increased or decreased in frequency among NT1 patients compared to GP. Among subjects with the HLA - DRB5*01 : 01 : 01-DRB1*15 : 01 : 01-DQA1*01 : 02-DQB1*06 : 02 haplotype, a second DRB4*01 : 03 : 01-DRB1*04 : 01 : 01-DQA1*03 : 02//*03 : 03 : 01-DQB1*03 : 01 : 01 haplotype ( p = 2.02E -2 ), but not homozygosity for DRB1*15 : 01 : 01-DQB1*06 : 02 : 01 ( p = 7.49E -1 ) conferred association to NT1. Alleles with increased frequency in DQA1*01 : 02 : 01 (p = 1.07E -2 ) and DQA1*03 : 02//*03 : 03 : 01 (p = 3.26E -2 ), as well as with decreased frequency in DRB3*01 : 01 : 02 (p = 8.09E -3 ), DRB1*03 : 01 : 01 ( p = 1.40E -2 ), and DQB1*02 : 01 : 01 ( p = 1.40E -2 ) were found among patients compared to their FDR. High-resolution HLA sequencing in Pandemrix-associated NT1 confirmed the strong association with the DQB1*06 : 02 : 01 -containing haplotype but also revealed an increased association to the not previously reported extended HLA - DRB4*01 : 03 : 01-DRB1*04 : 01 : 01-DQA1*03 : 02//*03 : 03 : 01-DQB1*03 : 01 : 01 haplotype. High-resolution HLA typing should prove useful in dissecting the immunological mechanisms of vaccination-associated NT1.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research